LWG-301
LWG-301 is an allosteric inhibitor of Glutaminase 1 (GLS1) with an IC50 value of 7 nM. LWG-301 significantly block glutamine metabolism, increases intracellular ROS, thus induces apoptosis. LWG-301 exhibits moderate antitumor effects in HCT116 xenograft model[1].
Product Specifications
CAS Number
3038480-88-2
UNSPSC
12352005
Target
Apoptosis; Glutaminase
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lwg-301.html
Solubility
10 mM in DMSO
Smiles
CCCCOC1=CC=CC(CC(NC2=NN=C(C=C2)N3CCC(CC3)NC4=NN=C(S4)NC(CCCC)=O)=O)=C1
Molecular Formula
C28H38N8O3S
Molecular Weight
566.72
References & Citations
[1]Chang X, et al. Design, synthesis, and biological evaluation of novel glutaminase 1 allosteric inhibitors with an alkane chain tail group. Eur J Med Chem. 2023 Jan 15;246:115014.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC063731-100 1x 100 µL
Tubulin beta 3 / TUBB3 (Neuronal & Stem Cell Marker) (TUBB3/3731), CF405L conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041911-500 1x 500 µL
ROR2 (ROR2/1911), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 